Metabolism, Diabetes, and Cancer
Metabolism, Diabetes, and Cancer is a research topic within Molecular Biology. Science Explorer counts 45k research works in it since 1950. 24.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the role of AMP-activated protein kinase (AMPK) in regulating cellular metabolism, including its involvement in glucose and lipid metabolism, insulin signaling, mitochondrial homeostasis, and the potential impact on cancer risk. The cluster also delves into the mechanisms of action of metformin, a drug known to activate AMPK and its effects on cellular energy balance and gene expression regulation.
- AMP-activated Protein Kinase
- Metformin
- Glucose
- Insulin Signaling
- Cancer Risk
- Cellular Energy
- Mitochondrial Homeostasis
- Glycogen Metabolism
- Regulation of Gene Expression
- Tumor Suppression
- Research works
- 45k fractional, since 1950
- In the world top 10%
- 11k per year above
- Top-10% rate
- 24.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +6% the tick is no change
Which countries lead Metabolism, Diabetes, and Cancer research?
By volume, China and the United States publish the most (1.3k and 1.2k works in 2022–2025).
By volume, 2022–2025
- 1 China 1.3k works
- 2 United States 1.2k works
- 3 India 349 works
- 4 Japan 256 works
- 5 South Korea 223 works
- 6 Italy 212 works
- 7 United Kingdom 202 works
- 8 Germany 173 works
- 9 Iran 128 works
- 10 Canada 125 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Metabolism, Diabetes, and Cancer research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Metabolism, Diabetes, and Cancer research, followed by University of North Carolina at Chapel Hill and Harvard University.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 25 works
- 2 University of North Carolina at Chapel HillUnited States 21 works
- 3 Harvard UniversityUnited States 19 works
- 4 Peking UniversityChina 17 works
- 5 Nanjing Medical UniversityChina 14 works
- 6 Sichuan UniversityChina 14 works
- 7 Shanghai Jiao Tong UniversityChina 14 works
- 8 Sun Yat-sen UniversityChina 13 works
- 9 University of CopenhagenDenmark 13 works
- 10 Central South UniversityChina 13 works
Who are the leading researchers in Metabolism, Diabetes, and Cancer?
The most-cited researchers publishing on Metabolism, Diabetes, and Cancer include Mark I. McCarthy.
- 1 Mark I. McCarthy United Kingdom 4.9k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Metabolism, Diabetes, and Cancer research done?
The largest centres of Metabolism, Diabetes, and Cancer research in 2022–2025 are Beijing (China), Shanghai (China), Seoul (South Korea) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Indianapolis.
Largest cities, 2022–2025
Where it is the local speciality
- IndianapolisUS · 23.5 works6.4×
Location quotient: how much more of its research is in Metabolism, Diabetes, and Cancer than the world average.
Where is the best place to study Metabolism, Diabetes, and Cancer?
Among universities, judged by research, Medical University of Lodz, Chinese Academy of Medical Sciences & Peking Union Medical College and University of Copenhagen score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Medical University of LodzPoland | 61.8 | 50.2% | 9.3× | 8 | +69.0% |
| 2 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 58.0 | 35.7% | 4.4× | 25 | +59.4% |
| 3 | University of CopenhagenDenmark | 46.8 | 39.8% | 3.2× | 13 | -5.7% |
| 4 | Harvard UniversityUnited States | 46.7 | 36.2% | 2.5× | 19 | -22.8% |
| 5 | China Medical UniversityChina | 46.0 | 43.9% | 5.5× | 10 | -0.9% |
| 6 | Medical University of SilesiaPoland | 43.7 | 22.7% | 9.4× | 10 | +5.8% |
| 7 | Wenzhou Medical UniversityChina | 43.2 | 29.7% | 4.3× | 9 | +278.1% |
| 8 | National and Kapodistrian University of AthensGreece | 42.6 | 41.9% | 3.1× | 9 | +60.8% |
| 9 | Nanjing Medical UniversityChina | 42.1 | 29.2% | 4.8× | 14 | +18.3% |
| 10 | Sichuan UniversityChina | 40.8 | 41.1% | 1.4× | 14 | +30.0% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Metabolism, Diabetes, and Cancer research growing?
Output in 2018–2022 was 6% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Metabolism, Diabetes, and Cancer.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.